A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV

被引：0
|
作者：
Alfredo Pece
Paolo Milani
Carla Monteleone
Costantino John Trombetta
Giuseppe De Crecchio
Giuseppe Fasolino
Domenica Matranga
Salvatore Cillino
Maria Vadalà
机构：
[1] Ospedale di Melegnano,Unità operativa di Oftalmologia
[2] Fondazione Retina 3000,Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche, Sezione di Oftalmologia
[3] Università di Palermo,Dipartimento di Specialità Chirurgiche, Sezione di Oftalmologia
[4] Università di Messina,Dipartimento di Scienze Oftalmologiche
[5] Università di Napoli,Dipartimento di Scienze per la Promozione della Salute e Materno Infantile
[6] Retina Center,undefined
[7] Università di Palermo,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2015年 / 253卷
关键词：
Pathological myopia; CNV; Bevacizumab; Ranibizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1867 / 1872
页数：5
相关论文
共 50 条
  • [1] A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV
    Pece, Alfredo
    Milani, Paolo
    Monteleone, Carla
    Trombetta, Costantino John
    De Crecchio, Giuseppe
    Fasolino, Giuseppe
    Matranga, Domenica
    Cillino, Salvatore
    Vadala, Maria
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 253 (11) : 1867 - 1872
  • [2] A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV
    Tan, Colin S.
    Cheong, Kai Xiong
    Lim, Louis W.
    Tan, Shoun
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (07) : 1433 - 1434
  • [3] A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV
    Colin S. Tan
    Kai Xiong Cheong
    Louis W. Lim
    Shoun Tan
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2016, 254 : 1433 - 1434
  • [4] INTRAVITREAL RANIBIZUMAB VERSUS BEVACIZUMAB FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION
    Iacono, Pierluigi
    Parodi, Maurizio Battaglia
    Papayannis, Alessandro
    Kontadakis, Stylianos
    Sheth, Saumil
    Cascavilla, Maria Lucia
    Bandello, Francesco
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (08): : 1539 - 1546
  • [5] A Prospective Randomized Trial of Intravitreal Bevacizumab Versus Ranibizumab for the Management of Diabetic Macular Edema
    Nepomuceno, Antonio Brunno
    Takaki, Erika
    Paes de Almeida, Felipe Piacentini
    Peroni, Renato
    Cardillo, Jose Augusto
    Siqueira, Rubens Camargo
    Scott, Ingrid Ursula
    Messias, Andre
    Jorge, Rodrigo
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2013, 156 (03) : 502 - 510
  • [6] Choroidal Neovascularization in Pathologic Myopia: Intravitreal Ranibizumab Versus Bevacizumab-A Randomized Controlled Trial
    Gharbiya, Magda
    Giustolisi, Rosalia
    Allievi, Francesca
    Fantozzi, Nicoletta
    Mazzeo, Luigi
    Scavella, Vittorio
    Gabrieli, Corrado Balacco
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (03) : 458 - 464
  • [7] Intravitreal Bevacizumab vs. Combination of Intravitreal Bevacizumab plus Macular Photocoagulation in Clinically Significant Diabetic Macular Edema: 6 months Results of a Randomized Clinical Trial
    Faghihi, Hooshang
    Esfahani, Mohammad Riazi
    Harandi, Zahra Aalami
    Madani, Shahram
    IRANIAN JOURNAL OF OPHTHALMOLOGY, 2010, 22 (01): : 21 - 26
  • [8] Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion A Randomized Clinical Trial
    Hykin, Philip
    Prevost, A. Toby
    Vasconcelos, Joana C.
    Murphy, Caroline
    Kelly, Joanna
    Ramu, Jayashree
    Hounsome, Barry
    Yang, Yit
    Harding, Simon P.
    Lotery, Andrew
    Chakravarthy, Usha
    Sivaprasad, Sobha
    Eleftheriadis, Haralabos
    Briggs, Michael
    Williams, Michael
    Abugreen, Salwa
    Ghanchi, Faruque
    Narendran, Nirodhini
    Hughes, Edward
    Ross, Adam
    Gupta, Nitin
    Turner, Stephen
    Osoba, Yinka
    Patel, Jignesh
    Pagliarini, Sergio
    Lip, Peck-Lin
    Patel, Nishal
    Jafree, Afsar
    Menon, Geeta
    Patra, Sudeshna
    Burton, Ben
    Taylor, Simon
    Mackenzie, Sarah
    Gale, Richard
    Vadivelu, Komala
    McKibbin, Martin
    George, Sheena
    Almeida, Goncalo
    Sen, Piyali
    Patrao, Namritha
    Menon, Deepthy
    Nicholson, Luke
    D'Souza, Yvonne
    Talks, James
    Sundaram, Venki
    Banerjee, Sanjiv
    Habib, Maged
    Ram, Raghu
    Brand, Christopher
    Newman, Douglas
    JAMA OPHTHALMOLOGY, 2019, 137 (11) : 1256 - 1264
  • [9] Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic review
    Schmucker, Christine
    Ehlken, Christoph
    Hansen, Lutz L.
    Antes, Gerd
    Agostini, Hansjuergen T.
    Lelgemann, Monika
    CURRENT OPINION IN OPHTHALMOLOGY, 2010, 21 (03) : 218 - 226
  • [10] Bevacizumab helps with CNV in high myopic eyes
    Bitzer, Michaela
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2009, 226 (10) : 784 - 784
12345